357 Results (Page 10 of 15)
Indonesia Markets Research Reports
Indonesia Haematology Market Analysis
Indonesia Haematology Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increasing frequency of blood disorders, technological improvements, the growing elderly population, and increased desire for customised medicine and focused therapies are key drivers of the haematology market. Abbott Laboratories, Sysmex Corporation, Roche Diagnostics, Siemens Healthineers, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., Danaher Corporation (Beckman Coulter), HORIBA Ltd., Ortho Clinical Diagnostics, and Agilent Technologies are the global players in the haematology market.
Indonesia Hangover Rehydration Supplements Market Analysis
Indonesia Hangover Rehydration Supplements Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The growing ageing population and prevalence of chronic diseases, breakthroughs in medication discovery and technology, and increased access to healthcare in emerging economies are all key drivers of the Hangover Rehydration Supplements Market. Gatorade (PepsiCo), Pedialyte (Abbott Laboratories), Liquid IV, Flyby, Blowfish for Hangovers, Cheers Health Inc., Bytox, Morning Recovery, Resync Recovery Blend, and Hydrant are the global key players in the Hangover Rehydration Supplements Market.
Indonesia Head and Neck Cancer Drugs Market Analysis
Indonesia Head and Neck Cancer Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Key drivers of the head and neck cancer drugs market in the USA include the increasing incidence of head and neck cancer, advancements in treatment options, rising demand for personalized medicine, and supportive government initiatives. Global Companies in Head and Neck Cancer Drugs Market are Bristol Myers Squibb Company, Merck & Co., Inc., Pfizer Inc., AstraZeneca plc, Novartis AG, Eli Lilly and Company, Amgen Inc., GlaxoSmithKline plc, Johnson & Johnson, Sanofi, Roche Holding AG, Takeda Pharmaceutical Company Limited, Bayer AG, AbbVie Inc. and Eisai Co., Ltd.
Indonesia Heart Failure Drugs Market Analysis
Indonesia Heart Failure Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The drivers of the heart failure drugs market include the increasing prevalence of heart failure, the aging population, advancements in drug therapies, rising awareness and diagnosis, and supportive government initiatives. Novartis AG, Pfizer Inc., AstraZeneca plc, Johnson & Johnson, Merck & Co., Bristol Myers Squibb Company, Boehringer Ingelheim International GmbH, Bayer AG, GlaxoSmithKline plc and Amgen are global key players in Heart Failure Drugs market.
Indonesia Hematopoietic Stem Cell Transplantation Market Analysis
Indonesia Hematopoietic Stem Cell Transplantation Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Two significant drivers driving the global market expansion for hematopoietic stem cell transplantation are leukaemia and lymphoproliferative disorders. Rising technical advancements and significant companies spending more money on R&D are expected to drive the market. Some of the major key players are Escape Therapeutics, Kite Pharma Inc., PromoCell GmbH, ScienCell Research Laboratories etc.
Indonesia Heparin Market Analysis
Indonesia Heparin Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Deep vein thrombosis (DVT) and pulmonary embolism (PE), expanding cardiac disorders, rising federal funding for improving health services and comprehensive research and development (R&D) activities, the rising incidence of chronic diseases, and the ageing population are some of the market drivers influencing the growth of the heparin market. The global Heparin market’s major key players are Sanofi S.A., Viatris Inc., Pfizer Inc., B. Braun Holding GmbH & Co. KG, etc.
Indonesia Hepatitis B Drugs Market Analysis
Indonesia Hepatitis B Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The factors such as growth of pharmaceutical industry, increase in ageing population, upsurge in healthcare expenditure, urbanization leading to better monitoring and screening procedures and increase in liver cancer and cirrhosis deaths due to HBV would drive the growth of Hepatitis B drugs market. Some of the major key players in this market are Apotex Inc, Accord Healthcare, Arbutus Biopharma, Aurobindo Pharma, Arrowhead Pharmaceuticals, Inc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, Gilead Sciences, Inc., Lupin Pharmaceuticals, Inc., etc.
Indonesia Antibacterial (Antibiotics) Drugs Market Analysis
Indonesia Antibacterial (Antibiotics) Drugs Market is at around $0.31 Bn in 2023 and is projected to reach $0.41 Bn in 2030, exhibiting a CAGR of 4.2% during the forecast period. The market is driven by rising infectious disease rates, improving healthcare infrastructure, and rising healthcare awareness. The market is dominated by key players like Kalbe Farma, Kimia Farma, Pfizer Inc., Roche, Novartis AG, GlaxoSmithKline plc, Abbott Laboratories, Johnson & Johnson, Merck & Co., Inc., and Sanofi S.A.
Indonesia Anemia Therapeutics Market Analysis
The Indonesia Anemia Therapeutics Market is anticipated to experience a growth from $89 Mn in 2022 to $178 Mn by 2030, with a CAGR of 9.1% during the forecast period of 2022-2030. The key drivers of the Indonesia Anemia Therapeutics Market include a greater emphasis on preventative treatment with better support from the government, and growing affordability and market access to anti-anemic drugs. The Indonesia Anemia Therapeutics Market encompasses various players across different segments, including Novartis, Roche, Bayer, Pfizer, GlaxoSmithKline (GSK), Kalbe Farma, Indofarma, Kimia Farma, Sanbe Farma, Pharos Indonesia, etc, among various others
Indonesia Dermatological Therapeutics Market Analysis
Indonesia Dermatological Therapeutics Market is at around $0.25 Bn in 2023 and is projected to reach $0.44 Bn in 2030, exhibiting a CAGR of 8.6% during the forecast period. The market is expanding due to an increase in dermatological disorders, increased awareness about skin diseases, and technological advancements. The market is dominated by key players like PT Kalbe Farma Tbk (IDN), PT Kimia Farma Tbk (IDN), PT Sanbe Farma (IDN), Almirall SA, Pfizer Inc., AbbVie Inc., Amgen Inc., Novartis AG, Johnson & Johnson, and GlaxoSmithKline Plc.
Indonesia Cardiovascular Drugs Market Analysis
Indonesia Cardiovascular Drug Market is at around $0.83 Bn in 2022 and is projected to reach $1.12 Bn in 2030, exhibiting a CAGR of 3.8% during the forecast period. The main elements propelling this industry's growth include the incidence of cardiovascular diseases, changing lifestyles, and the aging population. The market is dominated by key players like Kalbe Pharma, Kimia Pharma, Bristol-Myers Squibb Company, Pfizer Inc., Bayer AG, Janssen Pharmaceuticals, Inc., AstraZeneca, Sanofi, Novartis AG, and Gilead Sciences, Inc.
Indonesia Alopecia (Hair Loss) Therapeutics Market Analysis
The Indonesia Alopecia (Hair Loss) Therapeutics Market was valued at US $49 Mn in 2022, and is predicted to grow at (CAGR) of 7.50% from 2023 to 2030, to US $88 Mn by 2030. The key drivers of this industry include the surge in the prevalence of alopecia (hair loss), demand for new treatments, demographic shifts, and others. The industry is primarily dominated by players such as Johnson & Johnson, Lexington, Sun Pharmaceuticals, Capillus, and Follica Inc among others.
Indonesia Digital Therapeutics Market Analysis
Indonesia Digital Therapeutics Market is at around $37.2 Mn in 2023 and is projected to reach $200.43 Mn in 2030, exhibiting a CAGR of 27.2 % during the forecast period. Increasing healthcare awareness, partnerships, and collaborations, investment, and funding are the drivers propelling the market's expansion. The market is dominated by key players like Halodoc, Good Doctor, Omada Health Inc., 2Morrow Inc., Livongo Health Inc., WellDoc, Propeller Health, Canary Health, Noom Inc., Akili Interactive Labs Inc., and HYGIEIA.
Indonesia Allergy Therapeutics Market Analysis
Indonesia Allergy Therapeutics Market was valued at $139 Mn in 2022 and is estimated to reach $229 Mn in 2030, exhibiting a CAGR of 6.4% during the forecast period. The need for allergy treatment drugs is being driven by the rising prevalence of allergic disorders and related health problems. Sanofi, Novartis, Boehringer Ingelheim, GlaxoSmithKline (GSK), AstraZeneca, Abbott Laboratories, Bayer, PT Kalbe Farma, PT Pharos Indonesia and PT Sanbe Farma are the leading pharmaceutical companies that are presently operating in the market
Indonesia Alcohol Addiction Therapeutics Market Analysis
The Indonesia Alcohol Addiction Therapeutics Market is valued at around $4 Mn in 2022 and is projected to reach $7 Mn by 2030, exhibiting a CAGR of 6.3% during the forecast period. Increasing awareness campaigns, reduced stigma, expanding healthcare infrastructure, and a changing social landscape, drive the potential demand for addiction treatment services, especially among youth in Indonesia. The key players involved in the research, development, and distribution of Alcohol Addiction Therapeutics in Indonesia are Elli Lily, Lundbeck, AstraZeneca, Indivior, Alkermes, TEVA Pharmaceuticals, Merck & Co., Kimia Farma, Kalbe Farma and Osotspa among others
Indonesia Acute Lymphocytic Leukemia (ALL) Therapeutics Market Analysis
The Indonesia Acute Lymphocytic Leukemia (ALL) Therapeutics Market was valued at US $20 Mn in 2022, and is predicted to grow at (CAGR) of 7.8% from 2023 to 2030, to US $36 Mn by 2030. The key drivers of this industry include a surge in the incidence of acute lymphocytic leukemia cases, collaborations and partnerships, increased government funding initiatives, and other factors. The industry is primarily dominated by players such as Sanofi, Takeda, Bio Farma, Kalbe Farma among other players
Indonesia Autosomal Dominant Polycystic Kidney Disease Therapeutics Market Analysis
The Indonesia Autosomal Dominant Polycystic Kidney Disease Therapeutics Market was valued at US $6.6 Mn in 2022, and is predicted to grow at (CAGR) of 5.8% from 2023 to 2030, to US $10.4 Mn by 2030. The key drivers of this industry include the upward trend in the prevalence of autosomal dominant polycystic kidney disease, healthcare infrastructure, economic growth, and other factors. The industry is primarily dominated by players such as Otsuka, AceLink, Palladio, Reata, Xortx, Regulus, among others
Indonesia Age-Related Macular Degeneration Therapeutics Market Analysis
The Indonesia Age-Related Macular Degeneration (AMD) Therapeutics Market was valued at US $65 Mn in 2022, and is predicted to grow at a CAGR of 8.90% from 2023 to 2030, to US $128 Mn by 2030. The key drivers of this industry include the increased prevalence of age-related macular degeneration, evolving healthcare infrastructure, and other factors. The industry is primarily dominated by players such as Regeneron Pharmaceuticals, Novartis, Bayer, Roche, and Genetech, among others.
Indonesia Addiction Therapeutics Market Analysis
Indonesia addiction therapeutics market was valued at $61 Mn in 2022 and is estimated to reach $103 Mn in 2030, exhibiting a CAGR of 6.9% during the forecast period. The market for addiction therapies has grown rapidly due to the growing knowledge and identification of mental health concerns, including substance abuse and addiction. Some of the leading players operating in the market include Kalbe Farma, PT Sanbe Farma, PT Tempo Scan Pacific Tbk, PT Dexa Medica, Combiphar, PT Phapros Tbk, Abbott, Pfizer, Novartis AG and GSK.
Indonesia Actinic Keratosis Therapeutic Market Analysis
Estimates indicate that the Indonesia Actinic Keratosis Therapeutic Market will reach roughly $60 Mn by 2030, up from $41 Mn in 2022, growing at a CAGR of 4.9% during the anticipated period. Rising awareness, market expansion, and the discovery of novel treatment options are driving growth in the Indonesia Actinic Keratosis Therapeutic Market. Key players contributing to the growth of the AK treatment market in Indonesia include Sun Pharmaceuticals, Novartis, Bausch Health, GlaxoSmithKline, Almirall, Johnson and Johnson and Merck among others
Indonesia Sleep Disorders Market Analysis
This report presents a strategic analysis of the Indonesia Sleep Disorders Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Indonesia Sleep Disorders Market, offering unmatched value, accuracy, and expert insights.
Indonesia Pain Management Devices Market Analysis
This report presents a strategic analysis of the Indonesia Pain Management Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Indonesia Pain Management Devices Market, offering unmatched value, accuracy, and expert insights.
Indonesia Orphan Diseases Drugs Market Analysis
This report presents a strategic analysis of the Indonesia Orphan Diseases Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Indonesia Orphan Diseases Drugs Market, offering unmatched value, accuracy, and expert insights.
Indonesia Healthcare Insurance Market Analysis
Indonesia's healthcare insurance market is projected to grow from $12.16 Bn in 2022 to $21.85 Bn by 2030, registering a CAGR of 7.6% during the forecast period of 2022-30. The main factors driving the growth would be government initiatives, increasing investment, technological advancements, and an aging population. The market is segmented by component, provider, coverage, health insurance plans, and by end-user. Some of the major players include Lippo Insurance Health Protection, BNI Life, AXA, Prixa, GotoSehat, Collective Life, CoverPlus, Aman, ATM Sehat, Bandingin, AELL, Garbage Clinical Insurance and Investor Medika.
Indonesia ENT Devices Market Analysis
Indonesia's ENT Devices Market is projected to grow from $140 Mn in 2022 to $220 Mn by 2030, registering a CAGR of 6% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the Indonesia ENT devices market include Innonovatech Medica, Dharma Intisemesta, and Bina Medika Lestari.